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Abstract: The universal quorum sensing autoinducer, AI-2, is utilized by several bacteria. 
Analogs of AI-2 have the potential to modulate bacterial behavior. Selectively quenching 
the communication of a few bacteria, in the presence of several others in an ecosystem, 
using analogs of AI-2 is non-trivial due to the ubiquity of AI-2 processing receptors in 
many bacteria that co-exist. Herein, we demonstrate that when an AI-2 analog, isobutyl 
DPD (which has been previously shown to be a quorum sensing, QS, quencher in both 
Escherichia coli and Salmonella  typhimurium) is modified with ester groups, which get 
hydrolyzed once inside the bacterial cells, only QS in E. coli, but not in S. typhimurium, is 
inhibited. The origin of this differential QS inhibition could be due to differences in analog 
permeation of the bacterial membranes or ester hydrolysis rates. Such differences could be 
utilized to selectively target QS in specific bacteria amongst a consortium of other species 
that also use AI-2 signaling. 
Keywords: AI-2; DPD analog; quorum sensing inhibitor; ester pro-drug; lsr expression; 
autoinducer cell permeation; autoinducer processing; enteric bacteria  
 
1. Introduction 
Bacteria can exist as single entities as well as be part of a community of other bacteria (which could 
consist  of  same  or  different  species  of  bacteria).  In  either  lifestyle  (free  flowing  or  community), 
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bacteria communicate with their neighbors via small molecules called autoinducers (a process called 
quorum sensing, QS) [1]. It is now appreciated that QS controls the expression of virulence factors [2] 
or biofilm-associated genes [3,4] in a variety of clinically important bacteria. Consequently, interests 
in  identifying  the  small  molecules  that  are  implicated  in  bacterial  communication  as  well  as  the 
receptor proteins that are involved in the quorum sensing process have intensified [5–10].
 It has been 
assumed that strategies that target quorum-sensing processes and not viability of bacteria should lead 
to less pressure for bacteria to evolve resistance mechanism, although this assumption has not yet been 
clinically proven. There are several instances in nature whereby some bacteria develop strategies to 
quench  the  communication  of  other  bacteria  in  order  to  gain  some  competitive  advantage.  For 
example, the production of homoserine lactonases or acylases by Bacillus or Pseudomonas has been 
shown  to  lead  to  the  destruction  of  autoinducers  (homoserine  lactones)  produced  by  competing 
bacteria [11].
 Also, small molecules or autoinducers produced by some bacteria or hosts have been 
shown to disrupt the quorum sensing of others [12–14]. 
Several groups have been interested in the development of small molecules that could be used to 
inhibit autoinducer signaling in a variety of bacteria [15–22]. Most of these small molecules have been 
derivatives  of  the  natural  quorum  sensing  molecules.  For  example  Sugar [22],  Blackwell [23]  and 
others [24,25]  have demonstrated that  modifications  of the species specific homoserine autoinducer, 
called AI-1, afford analogs that could compete with the native signaling molecule. The Janda [19,26,27] 
and the Sintim [20,28] groups have focused on analogs of the universal quorum sensing molecule,  
AI-2.  AI-2  is  termed  universal  because  it  is  either  produced  or  sensed  by  over  seventy  different 
bacterial species. Analogs of AI-2 have been shown to either act as synergistic agonists in some Vibrio 
species [26,28] or antagonist [20] in enteric bacteria, such as E. coli and S. typhimurium. Interestingly, 
it has been demonstrated that the nature of the C1 acyl group in AI-2 analogs confers specificity in 
disrupting QS processes in a variety of bacteria [20]. For example, hexyl-DPD (an analog of AI-2, 
which  has  the  C1  methyl  group  in  the  native  compound  replaced  by  a  hexyl  group)  inhibits  
AI-2-mediated  lsr  expression  in  E.  coli  whereas  this  same  molecule  is  ineffective  against  
AI-2-mediated lsr expression in the analogous enteric bacteria, S. typhimurium. On the other hand, 
isobutyl DPD (for this analog, the methyl group is replaced with the isobutyl group) could inhibit  
AI-2-mediated lsr expression in S. typhimurium, implying that subtle differences in the C1 substituents 
of AI-2 could result in significant differences in biological response [20]. 
One of the limitations of the use of AI-2 analogs in selectively modulating bacterial behavior is the 
instability of these analogs. At high concentrations, it has been shown that AI-2 form dimers (see 
Figure 1), which are not biologically active [29]. This makes the purification of AI-2 or analogs on 
silica gel problematic and most studies that use synthetic AI-2 use unpurified molecules. Others have 
attempted to solve the instability issue associated with AI-2 by making ester derivatives that hydrolyze 
in vivo to release active autoinducers [30]. This strategy is promising in delivering purer and more 
stable AI-2 analogs that could be used in studying bacterial communication, with implications for 
disease control or synthetic biology applications. However, detailed study that correlates the nature of 
the ester group on AI-2 and biological activity has not been described. Additionally, as analogs of AI-2 
are emerging as potent anti-QS molecules [20], it is of interest to investigate if these QS signaling 
inhibitors could also be protected as ester “pro-drugs” and still retain their inhibitory activity. If different Sensors 2012, 12                               
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bacteria  processed  ester-protected  AI-2  analogs  differently,  then  one  could  selectively  modulate  the 
activity of specific bacteria in an ecosystem via the use of differently protected AI-2 analog. 
Figure 1. Structure of AI-2 dimer. 
 
 
 
 
 
2. Experimental Section  
2.1. Synthesis of Diazocarbonyls 
2.1.1. Generation of Diazomethane 
Diazomethane  was  generated  from  Diazald
®  (Sigma-Aldrich,  St.  Louis,  MO,  USA)  using  a 
diazomethane  generator  apparatus  (Sigma-Aldrich,  Oberkochen,  Germany),  following  the  protocol 
provided by Sigma-Aldrich (Oberkochen, Germany). Briefly, a solution of Diazald
® (5 g) in diethyl 
ether (45 mL) was slowly added to a solution of KOH (5 g) in mixed solvent (water (8 mL) and 
ethanol (10 mL)) at 65 ° C over 20 min. The generated diazomethane and the diethyl ether solvent 
distilled and was trapped in a collecting vessel using a dry ice/isopropanol bath to give diazomethane 
as a solution in diethyl ether (ca. 0.4–0.5 M). 
2.1.2. Addition of Diazomethane to Acyl Chlorides 
To a solution of diazomethane (3 equiv.) in diethyl ether was added an acyl chloride (1 equiv.) 
dropwise at 0 ° C. The resulting solution was allowed to stir for another 2 h and warmed up gradually 
to room temperature. The solvent was removed under vacuum and the diazocarbonyl residue (a yellow 
liquid) was used for the next step without further purification. 
2.2. Synthesis of Diazodiols  
DBU (0.16−0.20 equiv.) and 2-(tert-butyldimethylsilyloxy) acetaldehyde (1−1.5 equiv.) were added 
to a solution of the crude diazocarbonyl (1 equiv.) in anhydrous acetonitrile (0.2 M). The reaction was 
stirred at room temperature under nitrogen for 4−8 h and monitored by TLC. Upon disappearance of 
starting material, the reaction was quenched with sodium bicarbonate. The organic layer was extracted 
with dichloromethane (3 ×  20 mL) and dried with magnesium sulfate. The solvent was evaporated under 
reduced pressure. To a solution of crude product in anhydrous tetrahydrofuran at 0 ° C, TBAF was added 
(1−2  equiv.).  The  solution  was  allowed  to  warm  to  room  temperature  and  stirred  for  1−3  h  under 
nitrogen. The solvent was evaporated, and the crude product was purified by column chromatography. 
The products eluted as yellow oils using 1:3 to 3:2 ethyl acetate/hexane as the mobile phase. Sensors 2012, 12                               
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2.3. Synthesis of Ester Protected Diazo Compounds 
To  a  stirring  solution  of  diazodiol  (1  equiv.)  catalytic  4-dimethylaminopyridine  (DMAP)  and 
suspended 4 Å molecular sieves in dichloromethane (DCM) was added the requisite anhydride. The 
reaction was allowed to gently stir at room temperature for 2–4 h until complete disappearance of 
starting material was indicated by TLC. The crude reaction mixture was filtered washed with saturated 
aqueous  NaHCO3  solution  and  the  organic  phase  was  extracted  with  more  DCM.  The  combined 
organic phases were dried with anhydrous MgSO4 and the solvent was evaporated at reduced pressure. 
The crude product was purified by column chromatography. The products eluted as yellow oils using 
1:3 to 1:2 ethyl acetate/hexane as the mobile phase. 
2.4. Synthesis of DPDs  
Dimethyldioxirane in acetone (15−20 mL) was added dropwise to a solution of ester protected 
diazodiol (1 equiv.) in acetone (1−2 mL). The reaction was allowed to stir at room temperature (1−2 h) 
until complete disappearance of starting material was indicated by TLC (loss of UV activity). Solvent 
and excess reagents were evaporated under reduced pressure.  
2.5. Bacterial Strains and Growth Conditions  
Table 1 lists the bacterial strains used in this study. S. typhimurium and E. coli strains were cultured 
in  Luria-Bertani  medium  (LB,  Sigma,  St.  Louis,  MO,  USA).  These  antibiotics  were  used  for  the 
following strains: (60 μg∙mL
−1) kanamycin for S. typhimurium (MET715) and (50 μg∙mL
−1) ampicillin 
for E. coli (LW7). 
Table 1. Bacterial strains used in this study. 
Strain  Relevant genotype and/or property 
  Escherichia coli 
LW7  W3110ΔlacU160-tna2 ΔluxS: Kan 
(LuxS-deficient: does not produce AI-2) 
  Salmonella typhimurium 
MET715  rpsl putRA: Kan-lsr-lacZYA luxS: T-POP 
(LuxS-deficient: does not produce AI-2) 
 
2.6. Measurement of the QS Response (lsr Expression)  
The QS response indicated by lsr gene expression was analyzed in pure culture studies by culturing 
E. coli LW7 pLW11 and S. typhimurium MET715 overnight at 30 ° C in LB medium supplemented 
with appropriate antibiotics as stated previously. These cells were then diluted into fresh LB medium 
(with antibiotics) and grown to an OD600 of 0.4−0.8 at 37 °C, 250 rpm. Cells were then collected by 
centrifugation at 10,000×  g for 10 min and resuspended in 10 mM phosphate buffer. AI-2 (20  μM) and 
the respective analog (20  μM) were added to the E. coli or S. typhimurium suspension for 2 h at 37 ° C. 
AI-2 dependent β-galactosidase production was quantified by the Miller assay.  Sensors 2012, 12                               
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3. Results and Discussion 
The  syntheses  of  bis-ester  protected  AI-2  and  analogs  19–30  were  achieved  via  the  
strategy  shown  in  Scheme  1  [20,28].  Briefly,  an  aldol  reaction  between  diazocarbonyls  1–3  and  
2-(tert-butyldimethylsilyloxy)  acetaldehyde  afforded  diazodiols  4–6,  after  deprotection  of  the  TBS 
group with TBAF. Oxidation of the diazo group in diazodiols 4–6 afforded AI-2 or analogs but for the 
production of ester protected AI-2 and analogs, it was important to perform the esterification step first 
to give bis-ester 7–18 before the oxidation of the diazo bis-ester to give targeted compounds 19–30. 
Scheme 1. Synthetic strategy for making bis-ester protected AI-2 analogs.  
 
Reagents  and  conditions:  (a)  diazomethane,  0  ° C;  (b)  tert-butyl-siloxyacetaldehyde,  
DBU  (1,8  diazabicycloundec-7-ene),  CH3CN,  RT;  (c)  TBAF/THF.  DCM  =  dichloromethane;  
DMDO = dimethyldioxirane. 
 
With the various AI-2 or analog ester derivatives (methyl to pentyl esters, Figure 2) in hand, we 
proceeded to investigate the biological profiles of these esters. We have previously demonstrated that  
AI-2  analogs  with  longer  C1-acyl  chains  permeate  more  readily  into  bacterial  cells  than  shorter 
chains [31].  This  is  presumably  due  to  the  favorable  interactions  of  the  alkyl  chain  with  the 
phospholipid of the bacterial membrane. Based on this earlier work, we hypothesized that the longer 
chain ester derivatives (such as butyl or pentyl) would permeate more readily into bacterial cells than 
the shorter chain analogs, such as the methyl ester series [31]. However, if the cellular esterases were 
sensitive to the size of the esters, then the longer chain analogs would be hydrolyzed slower than the 
shorter  chain  ones.  Because  biological  activity  of  ester  prodrugs  is  dependent  on  permeation  and 
prodrug activation and both of these processes would depend on the organism in question, it is not 
always  easy  to  predict  a  priori  which  ester  group  is  most  suitable  for  derivatizing  biologically  
active molecules. 
Figure 2. Compounds evaluated as bis-ester protected AI-2 analogs. 
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Bis-ester-protected AI-2 analogs (with different ester chains; methyl, propyl, butyl and pentyl) were 
all effective lsr expression inducers in E. coli (see Figure 3). For S. typhimurium, it appears that LsrR 
is not as good a repressor (compared to  E. coli) and significant expression of the lacZ gene was 
observed even in the absence of added DPD (see control, Figure 3). Nonetheless, it is apparent that 
more LacZ protein was present in S. typhimurium in the presence of AI-2 than when AI-2 was not 
present [about 30% more LacZ present when AI-2 is added; see Figure 3, compare the histograms for 
“LuxS- + AI-2” and LuxS- (no AI-2 added)].  
Figure  3.  Black  bars:  AI-2  or  analogs-mediated  expression  of  β-galactosidase  in  
S.  typhimurium  (MET715:  LuxS
−).  Pink  bars:  AI-2  or  analogs-mediated  expression  of  
β-galactosidase in E. coli LW7/LuxS
−. AI-2 or bis-ester analogs of AI-2 (20 M) were 
added to the bacterial strains, which do not produce their own AI-2. Compounds 19–22 
represent  ester-protected  DPD  analogs:  19:  DPD  bis-methyl  ester;  20:  DPD  bis-propyl 
ester; 21: DPD bis-butyl ester; 22: DPD bis-pentyl ester. 
 
Therefore, even if lacZ expression is not solely controlled by AI-2, one can safely conclude that  
AI-2  plays  some  role  in  lacZ  expression  in  the  S.  typhimurium  [32].  The  origin  of  “leaky”  lacZ 
expression in the absence of LuxS, which makes AI-2, could be due to myriads of factors, such as a 
lower affinity of LsrR to the LsrR DNA binding region in S. typhimurium (compared to E. coli) or a 
higher concentration of other phosphorylated AI-2-like molecules (such as ribulose-5-phosphate) in  
S. typhimurium (compared to E. coli) or lower levels of LsrR in S. typhimurium (compared to E. coli) 
or even non-enzymatic production of AI-2 from ribulose-5-phosphate [33]. Without experimental data 
to pinpoint the origin of the differential lsr expression in S. typhimurium (compared to E. coli), it is 
dangerous to make definitive statements about the origin of this difference. Despite this high LacZ 
background in S. typhimurium, we can still conclude that the majority of the ester protected DPD 
analogs were not as good as DPD in inducing lsr expression in S. typhimurium, and only bis-butyl 
DPD appears to be as good as DPD (see Figure 3). It is important to note that DPD/AI-2 gets into  
S. typhimurium via a ribose transporter, such as LsrB, whereas the analogs would have to diffuse into 
the cells, probably via passive diffusion through the membrane. Hence the  marginal differences in Sensors 2012, 12                               
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activity  observed  between  bis-butyl  DPD  and  the  other  ester-protected  DPD  could  be  due  to 
differences  in  membrane  transport.  Next,  we  investigated  the  antagonistic  profile  of  the  bis-ester 
analogs  of  isobutyl  DPD  in  both  E.  coli  and  S.  typhimurium.  Isobutyl  DPD  is  an  antagonist  of  
AI-2-mediated QS in both E. coli and S. typhimurium and stable versions of this analog have the 
potential to disrupt QS processes in these enteric bacteria, which sometimes cause food-borne diseases. 
For  this  assay,  AI-2  was  added  to  a  LuxS-deficient  strain  of  E.  coli  (LW7)  or  S.  typhimurium 
(MET715)  to  induce  lsr  expression  via  the  derepression  of  LrsR  by  phospho-AI-2  [34].  
In E. coli, bis-methyl and bis-propyl DPD analogs were as effective QS quenchers as the unprotected 
isobutyl DPD (see Figure 4).  
Figure 4.  Inhibition of AI-2-mediated β-galactosidase expression in S. typhimurium (black 
bars) and E. coli (pink bars) with various bis-ester analogs of isobutyl DPD. [AI-2] = 20 M, 
[analogs] = 20 M. Compounds 23–26 represent ester protected isobutyl DPD analogs:  
23: isobutyl DPD bis-methyl ester; 24: isobutyl DPD bis-propyl ester; 25: isobutyl DPD  
bis-butyl ester; 26: isobutyl DPD bis-pentyl ester. 
 
 
Increasing  the  length  of  the  ester  chain  to  butyl  or  pentyl  either  reduced  (butyl)  or  abrogated 
(pentyl) the inhibitory profile of the DPD analog. In E. coli, the same trend was also observed for the 
bis-ester  derivatives  of  hexyl  DPD  (bis-methyl  and  bis-propyl  analogs,  but  not  butyl  or  pentyl 
derivatives, were QS inhibitors, Figure 5).  
In S. typhimurium, however, none of the bis-ester protected isobutyl DPD analogs were able to 
antagonize the action of AI-2. Addition of isobutyl DPD to S. typhimurium however decreased lacZ 
expression  by  about  50%  (compare  black  bar  corresponding  to  “isobutyl  DPD”  to  black  bar 
corresponding to “LuxS- + DPD” in Figure 4). Thus, S. typhimurium and E. coli have similar QS 
systems, but differences in the processing of ester analogs of isobutyl DPD allows for the selective 
modulation of QS processing in E. coli but not in S. typhimurium. 
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Figure 5. Inhibition of AI-2-mediated β-galactosidase expression in E. coli with various 
bis-ester analogs of hexyl DPD. [DPD] = 20 M, [analogs] = 20 M. Compounds 27–30 
represent ester protected hexyl DPD analogs; 27: hexyl DPD bis-methyl ester; 28: hexyl 
DPD bis-propyl ester; 29: hexyl DPD bis-butyl ester; 30: hexyl DPD bis-pentyl ester. 
 
4. Conclusions  
In conclusion, we have shown that ester derivatives of DPD analogs can be hydrolyzed inside 
bacterial cells to reveal the biologically active diol unit for quorum sensing disruption. We reveal that 
it is possible to achieve selectivity of QS modulation amongst closely related bacteria (in our case, 
between E. coli and S. typhimurium) via the use of ester protection of the diol unit of AI-2. The origin 
of  this  selectivity  remains  unknown  at  this  moment  but  it  could  be  a  number  of  several  factors, 
including selective permeation of the analogs or different sensitivities of the esterases required for 
analog hydrolysis in the different bacteria (Figure 6). Future work will be aimed at obtaining a more in 
depth molecular understanding of these interesting observations. This work adds to the growing list of 
different strategies that can be used to intercept AI-2 signaling in diverse bacteria [13,35–38]. 
Figure  6.  Proposed  model  of  action  in  enteric  bacteria.  Ester  protected  DPD  analogs 
diffuse into the cell, where esterases hydrolyze the ester pro-DPD and analogs and the 
DPD or analogs are subsequently phosphorylated by LsrK. 
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